Intellia Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $155.5M | $189.2M | $226.7M | $523.5M | $123.4M | $160.0M | $57.2M | $58.9M |
| Accounts Receivable | $9.5M | $8.5M | $36.5M | $3.8M | $2.0M | $2.1M | $4.6M | $7.5M |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $527.7M | $639.9M | $998.3M | $1.22B | $769.3M | $616.5M | $289.5M | $325.0M |
| Property, Plant & Equipment | $17.7M | $27.4M | $32.8M | $27.9M | $21.0M | $15.9M | $18.0M | $17.1M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $842.1M | $1.19B | $1.30B | $1.52B | $1.29B | $676.3M | $334.3M | $347.3M |
| Liabilities | ||||||||
| Accounts Payable | $20.3M | $14.6M | $7.5M | $5.2M | $9.7M | $10.5M | $3.9M | $2.7M |
| Total Current Liabilities | $103.9M | $110.9M | $115.2M | $126.6M | $125.8M | $64.3M | $35.6M | $40.6M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $170.7M | $319.1M | $250.8M | $284.5M | $254.2M | $149.3M | $64.4M | $69.4M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-2.59B | $-2.18B | $-1.66B | $-1.18B | $-703.0M | $-435.1M | $-300.9M | $-201.0M |
| Total Stockholders' Equity | $671.4M | $872.0M | $1.05B | $1.24B | $1.04B | $527.1M | $269.9M | $277.9M |